Cargando…

Immunodeficiency and Thymoma: A Case Report on Good Syndrome, a Diagnosis Frequently Missed and Forgotten

Patient: Male, 55-year-old Final Diagnosis: CMV infection • Good syndrome • thymoma Symptoms: Recurrent infection preceded by thymoma Medication:— Clinical Procedure: — Specialty: Hematology • Immunology • Oncology • Ophthalmology • Surgery OBJECTIVE: Rare disease BACKGROUND: Good syndrome (thymoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Andy Sing Ong, Loh, Wei Huei, Wong, Qi Ying, Yeo, Siaw Tze, Ng, Wei Loon, Teoh, Pak Inn, Fam, Tem Lom, Chew, Lee Ping, Chua, Hock Hin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970526/
https://www.ncbi.nlm.nih.gov/pubmed/33712551
http://dx.doi.org/10.12659/AJCR.928659
Descripción
Sumario:Patient: Male, 55-year-old Final Diagnosis: CMV infection • Good syndrome • thymoma Symptoms: Recurrent infection preceded by thymoma Medication:— Clinical Procedure: — Specialty: Hematology • Immunology • Oncology • Ophthalmology • Surgery OBJECTIVE: Rare disease BACKGROUND: Good syndrome (thymoma with immunodeficiency) is a frequently missed and forgotten entity. It is a rare cause of combined B and T cell immunodeficiency in adults. To date, fewer than 200 patients with Good syndrome have been reported in the literature. CASE REPORT: We report a case of type AB Masaoka-Koga stage I thymoma which predated the evidence of immune dysregulation by 5 years, manifesting as bilateral cytomegalovirus retinitis, multiple bouts of pneumonia, and bronchi-ectasis in a HIV-seronegative 55-year-old man. Intravitreal ganciclovir was administered in addition to intravenous systemic ganciclovir, which resulted in severe neutropenic sepsis. A thorough immunodeficiency workup confirmed the presence of hypogammaglobulinemia with complete absence of B cells and reduced CD4/CD8 ratio. The patient responded well to monthly intravenous immunoglobulin replacement therapy, with no further episodes of infection since then. The immunoglobulin level doubled after 1 year of treatment. However, as the patient refused further intravitreal and CMV-targeted treatment, his vision did not recover. CONCLUSIONS: Clinicians should be aware that thymoma can precede the onset of immunodeficiency. Clinical suspicion should be heightened in at-risk patients who present with multiple bouts of infection, particularly in thymoma cases with adult-onset immune dysfunction. It is of paramount importance to follow up those patients with annual clinical reviews and immunodeficiency screening.